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Plasmodium vivax, a relatively neglected human ma-
laria parasite, is a major public health challenge for Cen-
tral and South America, the Middle East, Central, South 
and Southeast Asia, Oceania and East Africa, where 
2.85 billion people are currently at risk of infection and 
70-80 million clinical cases are reported each year (Mu-
eller et al. 2009, Guerra et al. 2010). The emergence of 
drug-resistant strains and severe (sometimes fatal) dis-
ease challenges the traditional view of vivax malaria as 
a benign infection (Price et al. 2009). Recent epidemio-
logical trends in Brazil illustrate the importance of P. 
vivax as a re-emerging pathogen. The annual incidence 
of Plasmodium falciparum (the predominant malaria 
parasite species between 1985-1990) decreased steadily 
during the 1990s, while that of P. vivax maintained an 
upward trend. Both P. falciparum and P. vivax are still 
transmitted across the Amazon Basin, with rare Plasmo-
dium malariae infections. However, P. vivax now causes 
85% of the 315,000 malaria cases reported in this coun-
try each year (Oliveira-Ferreira et al. 2010), suggesting 
that this species may be less susceptible to the malaria 
control strategies currently used in Brazil. 
Understanding the genetic structure of P. vivax is 
essential to accurately describing the transmission dy-
namics of vivax malaria. Population genetics data are 
crucial, for example, to predict how fast phenotypes 
of interest, such as novel antigenic variants, particular 
relapsing patterns or drug resistance, arise and spread 
in natural populations (Zilversmit & Hartl 2005). The 
current data on P. vivax population genetics lags behind 
that of P. falciparum, primarily due to the scarcity of ap-
propriate genetic markers. As we cannot propagate the 
parasite in continuous culture in vitro (Udomsangpetch 
et al. 2008), the phenotypic diversity of natural human 
infections from P. vivax remained unexplored until the 
early 1990s. Advances in molecular methods, especially 
implementation of polymerase chain reaction (PCR)-
based protocols to amplify parasite DNA, allowed for 
genotyping of malaria parasite samples obtained directly 
from patient blood, without a preceding in vitro culture 
step (Kimura et al. 1990). The relative paucity of genetic 
markers hampers further investigation into the geno-
types that underlie phenotypes such as relapse pattern, 
virulence and drug resistance.
In this review, we broadly classify the available mo-
lecular markers into two groups: (i) markers that are 
clearly under natural selection, that is, markers that map 
to genome regions associated with adaptive traits and (ii) 
markers that are neutral or nearly neutral, that is, those 
that are not obviously influenced by natural selection. 
The extensive polymorphism found in loci associated 
with P. vivax adaptive traits, such as those coding for 
surface antigens and drug-resistance (Cui et al. 2003a), 
reflects the combined effects of the parasite′s population 
history and selective constraints imposed by the host′s 
immunity and drug usage (Escalante et al. 2004). Thus, 
these loci do not provide much information on the P. 
vivax population structure. Neutral and nearly neutral 
markers, in contrast, may allow for unbiased estimates 
of genetic variation, population structure and gene flow 
in natural parasite populations. 
When comparing different markers and parasite typ-
ing systems, a clear quantitative definition of genetic 
diversity is required. One of the most popular methods 
of summarising genetic diversity levels is to report vir-
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Enhanced understanding of the transmission dynamics and population genetics for Plasmodium vivax is crucial 
in predicting the emergence and spread of novel parasite phenotypes with major public health implications, such 
as new relapsing patterns, drug resistance and increased virulence. Suitable molecular markers are required for 
these population genetic studies. Here, we focus on two groups of molecular markers that are commonly used to 
analyse natural populations of P. vivax. We use markers under selective pressure, for instance, antigen-coding poly-
morphic genes, and markers that are not under strong natural selection, such as most minisatellite and microsatellite 
loci. First, we review data obtained using genes encoding for P. vivax antigens: circumsporozoite protein, merozoite 
surface proteins 1 and 3α, apical membrane antigen 1 and Duffy binding antigen. We next address neutral or nearly 
neutral molecular markers, especially microsatellite loci, providing a complete list of markers that have already 
been used in P. vivax populations studies. We also analyse the microsatellite loci identified in the P. vivax genome 
project. Finally, we discuss some practical uses for P. vivax genotyping, for example, detecting multiple-clone infec-
tions and tracking the geographic origin of isolates.
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tual heterozygosity (HE) values. Virtual HE is the aver-
age probability that a pair of alleles randomly obtained 
from the population is different. Whenever appropriate, 
in this review we provide HE estimates obtained using 
different markers for different populations.
Molecular markers under selection - Until recently, 
most genetic markers available for characterising natu-
ral P. vivax populations were orthologues of previously 
identified P. falciparum antigen-coding genes. The well-
characterised polymorphic regions in these genes have 
been extensively used to analyse genetic diversity pat-
terns in P. falciparum (Roy et al. 2008). A similar ap-
proach has been explored in vivax-oriented studies (Cui 
et al. 2003a). The following single-copy genes in P. vivax 
have often been used in these studies: gam1, coding for 
the gametocyte antigen 1, csp, coding for the circumspo-
rozoite protein (CSP), msp1 and msp3alpha, coding for the 
merozoite surface proteins (MSP)-1 and 3α, respectively, 
ama1, coding for the apical membrane antigen 1, and dbp, 
coding for the Duffy binding protein (DBP) (Table I).
A notable feature of several P. vivax surface anti-
gens (including major vaccine-candidate molecules) 
is tandem arrays of relatively short amino acid motifs. 
The CSP in P. vivax (PvCSP), an abundant antigen on 
the surface of sporozoites that has been extensively 
used as a vaccine development target, has immuno-
dominant B-cell epitopes that map to central repeats 
between nonrepetitive sequences (Nardin & Zavala 
1998). PvCSP displays two major types of nonapep-
tide repeats [most commonly GDRA(D/A)GQPA and 
ANGA(G/D)(N/D)QPG], which define the variants 
known as VK210 and VK247, respectively (Arnot et al. 
1985, Rosenberg et al. 1989) (Fig. 1). Both VK210 and 
VK247 variants are globally distributed, but geograph-
ic biases have been described (Cochrane et al. 1990, 
Qari et al. 1993a, b). Similar repetitive sequences are 
found in Brazil, Southeast Asia and Papua New Guinea 
(Qari et al. 1991, 1992). However, markedly divergent 
sequence variants were found in isolates from China 
and North Korea (Mann et al. 1994). Although VK210 
and VK247-type sequences often occur in sympatric 
parasite populations, there are no examples of a hybrid 
repeat array with both repeat types (Lim et al. 2005).
A third type of repeat unit [APGANQ(E/G)GAA], 
identical to that described for Plasmodium simiovale, 
characterises the so-called P. vivax-like parasites (Qari et 
al. 1993a). Although P. vivax-like CSP repeats have been 
found in parasite isolates across the world, its global dis-
tribution remains unconfirmed (Gopinath et al. 1994). In 
Brazil, P. vivax-like parasites have been identified only in 
mixed-clone infections with VK210-type or VK247-type 
parasites (Machado & Póvoa 2000). More recently, com-
plex mixtures of parasites harbouring several PvCSP types 
and co-infecting the same hosts have been demonstrated 
by Henry-Halldin et al. (2011) in Papua New Guinea.
The nonapeptide sequences in PvCSP are repeated 
~20 times in the array. Insertions and deletions in the 
central repeat domain, from either sexual recombination 
during meiosis or intrahelical strand-slippage events 
during mitotic DNA replication (McConkey et al. 1990), 
generate novel CSP variants that may be positively select-
ed if the mutant parasites evade a host’s immunity. The 
central repetitive domain of P. falciparum CSP (PfCSP) 
contains extensive variation. This domain consists of a 
variable number of four-mer NANP and NVDP motif 
copies without breaking down the tight linkage between 
polymorphic sites in flanking sequences, as in interhe-
lical exchanges during meiosis (Rich et al. 1997). This 
pattern suggests that these repeats undergo frequent in-
Fig. 1: schematic representation of studied antigens: A: the circum-
sporozoite protein of Plasmodium vivax (PvCSP) consists of a con-
served region (light grey) flanking a repeated central region (RCR) 
(blank box), which contains immunodominant B-cell epitopes and is 
flanked by pre and post-repeat specific nonrepetitive sequences (NR) 
(black boxes). PvCSP displays three types of repeats [GDRA(D/A)
GQPA (VK210), ANGA(G/D)(N/D)QPG (VK247)] which are the most 
prevalent and APGANQ[E/G]GGAA (P. vivax-like); B: the P. vivax 
merozoite surface protein 1 (PvMSP-1) sequence comprises seven 
conserved blocks (amino acid similarity among PvMSP-1 alleles, 
71-85%) (light grey boxes) and six variable blocks (amino acid simi-
larity, 21-34%) (black boxes), described by Putaporntip et al. (2002). 
For comparison, we also show the original division of PvMSP-1 into 
interspecies conserved blocks (ICBs) (amino acid similarity > 48% 
in pairwise comparisons of MSP-1 orthologues in Plasmodium falci-
parum, P. vivax and Plasmodium yoelii) (light grey boxes), conserved 
blocks (CBs) (amino acid similarity > 50% between P. falciparum and 
P. vivax, but lower in other pairwise comparisons) (dark grey boxes) 
and polymorphic blocks (amino acid similarity < 45%) (black boxes) 
(del Portillo et al. 1991). These two methods of portioning PvMSP-1 
differ in that Putaporntip et al. (2002) compared intraspecific se-
quences, while del Portillo et al. (1991) compared between-specific 
sequences. The F1, F2 and F3 were defined by Imwong et al. (2005) 
(horizontal bold lines); C: the P. vivax merozoite surface protein 3α 
(PvMSP-3α) contains an alanine-rich central polymorphic region 
(blank box), which could be partially deleted, generating three types 
of proteins with different sizes. This region is flanked by semi-con-
served regions (SC) (grey boxes) and by conserved regions (CR) (light 
grey boxes); D: the P. vivax apical membrane antigen 1 (PvAMA-1) 
displayed three domains in its ectodomain, referred to as domain I, II 
and III; E: the P. vivax Duffy binding protein (PvDBP) is schemati-
cally divided in seven domains: II [Duffy binding-like domain (DBL)] 
and VI are cysteine-rich domains. The DBL domain is the most poly-
morphic and responsible for the interaction with the Duffy antigen at 
the erythrocyte surface; CT: cytoplasmic tail; PS: pro sequence; SS: 
signal peptide; TM: transmembrane domain.
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TABLE I
Genes encoding antigens used as molecular markers to study field populations of Plasmodium vivax
Antigen
Protein
fragment
Population studied
(n)
Totala
(n) References
PvAMA-1 Domain I BRA 105 Grynberg et al. (2008)
20 Rodrigues et al. (2005)
KOR 30 Chung et al. (2003)
22 Han et al. (2002)
MYA 76 Moon et al. (2010)
AFR (5), CHI (5), IND (18), INDO (5),  
PHI (148), PNG (23), SI (7), THAI (6)
219 Figtree et al. (2000)
Domain I, II IND 61 Thakur et al. (2008)
Whole IND 11 Rajesh et al. (2007)
SRL 23 Gunasekera et al. (2007)
THAI 231 Putaporntip et al. (2009)
VEN 73 Ord et al. (2008)
PvCSP CR AFG 202 Zakeri et al. (2010)
AZE 36 Leclerc et al. (2004)
BRA 48 Machado and Póvoa (2000)
45 Patil et al. (2010)
32 Santos-Ciminera et al. (2007)
155 Storti-Melo et al. (2009)
Central AME, South AME, AFR, Southeast ASI, IND 126 Gopinath et al. (1994)
COL 24 Hernández-Martínez et al. (2011)
GUY 61 Bonilla et al. (2006)
IND 151 Kim et al. (2006)
IRA 144 Zakeri et al. (2006)
KOR 632 Choi et al. (2010)
MYA 116 Moon et al. (2010)
PAK 187 Zakeri et al. (2006)
PAK (187), IRA (150) 337 Zakeri et al. (2010)
PNG 40 Kolakovich et al. (1996)
507 Henry-Halldin et al. (2011)
THAI 90 Cui et al. (2003b)
100 Imwong et al. (2005)
171 Kain et al. (1993)
17 Rongnoparut et al. (1995)
CR, NR BRA (30), PNG (14) 30 Qari et al. (1992)
N, C-end PHI, CHI, SI, PNG 18 Huang et al. (1994) 
Whole CHI 16 Mann et al. (1994)
PvDBP Whole COL 23 Martinez et al. (2004) 
Domain II-IV South KOR 30 Kho et al. (2001)
Domain II BRA 40 Sousa et al. (2006)
122 Sousa et al. (2010)
COL 20 Ampudia et al. (1996)
COL (18), South KOR (14), PNG (68) 100 Cole-Tobian et al. (2002)
IRA 75 Babaeekho et al. (2009)
PNG 40 Kolakovich et al. (1996)
358 Cole-Tobian et al. (2002)
50 Tsuboi et al. (1994)
24 Xainli et al. (2000)
THAI 30 Gosi et al. (2008)
Domain II, III KOR 8 Suh et al. (2001)
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Antigen
Protein
fragment
Population studied
(n)
Totala
(n) References
PvMSP-1 Pv200L COL 26 Valderrama-Aguirre et al. (2011)
925 pb PHI, CHI, SI, PNG 18 Cheng et al. (1993) 
BL 2 BRA (28), VIET (23) 51 Hoffmann et al. (2003)
ICBs 2-4 COL 20 Gutierrez et al. (2000)
ICBs 4, 5 AFR (5), CHI (10), IND (21), INDO (11),  
PHI (97), PNG (21), SI(6), THAI (4)
175 Figtree et al. (2000)
KOR 30 Kim et al. (2009)
ICBs 5, 6 
or 
BL 5
AZE 36 Leclerc et al. (2004)
BRA 32 Santos-Ciminera et al. (2007)
French GUY 120 Veron et al. (2009)
IND 25 Farooq et al. (2009)
IND (9), COL (11) 20 Maestre et al. (2004)
KOR 632 Choi et al. (2010)
25 Lim et al. (2000)
MYA 116 Moon et al. (2009)
PNG 40 Kolakovich et al. (1996)
PAK (187), IRA (150) 337 Zakeri et al. (2010)
SRL 22 Premawansa et al. (1993)
THAI 15 Putaporntip et al. (1997)
F1-F3 IND 151 Kim et al. (2006)
THAI 100 Imwong et al. (2005)
F1, F3 PNG 93-108 Koepfli et al. (2009)
MSP-142 SRL 95 Dias et al. (2011)
IND 33 Thakur et al. (2008)
MSP-119 BRA 28 Soares et al. (1999)
GUY 61 Bonilla et al. (2006)
C-terminal PHI (4) THAI (3) SI (8), PNG (1), South East ASI (4) 20 Pasay et al. (1995)
Whole THAI (20), BRA (8), BAN (5), South KOR (4), VAN (2), IND (1) 40 Putaporntip et al. (2002)
KOR 45 Han et al. (2011)
TUR 30 Zeyrek et al. (2010)
PvMSP-3α NA IND 151 Kim et al. (2006)
COL 55 Cristiano et al. (2008)
French GUY 120 Veron et al. (2009)
IND 27 Prajapati et al. (2010)
IRA 144 Zakeri et al. (2006)
MYA 116 Moon et al. (2009) 
PAK 50 Khatoon et al. (2010)
PAK (187), IRA (150) 337 Zakeri et al. (2010)
PER 186 Sutton et al. (2009)
PNG 28 Bruce et al. (2000)
11 Mueller et al. (2002)
PNG (39), IND (4), Sudan (1), SRL (1) 45 Bruce et al. (1999)
South KOR 24 Han et al. (2004) 
THAI 90 Cui et al. (2003b)
VEM 58 Ord et al. (2005)
Whole THAI 17 Mascorro et al. (2005)
a: number of P. vivax infected patients studied in genotyping; AFG: Afghanistan; AFR: Africa; AMA: apical membrane anti-
gen; AME: America; ASI: Asia; AZE: Azerbaijan; BAN: Bangladesh; BL: polymorphic block (Putaporntip et al. 1997); BRA: 
Brazil; CHI: China; COL: Colombia; CR: central repeatitive; CSP: circumsporozoite protein; DBP: Duffy binding protein; ICB: 
interspecies conserved blocks (del Portillo et al. 1991); IND: India; INDO: Indonesia; IRA: Iran; KOR: Korea; MSP: merozoite 
surface protein; MYA: Myanmar; NA: not applied restriction fragment length polymorphism-polymerase chain reaction; NR: 
non-repetitive; PAK: Pakistan; PER: Peru; PHI: Philippines; PNG: Papua New Guinea; Pv: Plasmodium vivax; SI: Solomon 
Islands; SRL: Sri Lanka; THAI: Thailand; TUR: Turkey; VAN: Vanuatu; VEN: Venezuela; VIET: Vietnam.
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trahelical recombination that either add or delete repeat 
units during mitotic DNA replication (Fig. 2), as other 
short repeats, such as microsatellite and minisatellite-
type sequences (Levinson & Gutman 1987). Frequent 
mitotic recombination coupled with positive selection of 
new variants might accelerate sequence evolution even 
where meiotic recombination and outcrossing are rela-
tively uncommon in malaria parasite populations (Rich 
et al. 2000). In length variation arrays, whether length 
variation affects B-cell epitope recognition is uncertain, 
but the conformational nature of repetitive epitopes in 
PfCSP (Monette et al. 2001) supports this hypothesis.
We have recently examined whether similar recom-
bination mechanisms create significant variation in the 
PvCSP repeat arrays, which consist of longer (9-mer) 
repetitive motifs (Patil et al. 2010). We investigated pat-
terns of sequence diversity in PvCSP encoding gene al-
leles in sympatric P. vivax isolates from an area of low 
malaria endemicity in Brazil. In these isolates, we used 
single-nucleotide polymorphism typing to examine the 
haplotype structure of chromosome 8, where the PvC-
SP encoding gene is located. We sought to determine 
whether the repetitive domain in the csp locus was 
significantly diverse under conditions of low malaria 
endemicity, which reduces effective meiotic recombi-
nation rates in local parasites. We confirmed previous 
findings (Arnot et al. 1985, 1990, Qari et al. 1992, 1994, 
Mann et al. 1994) of substantial nucleotide sequence 
diversity in repeat arrays from 45 isolates. They were 
analysed using nine different csp alleles, each with a 
unique arrangement of six different nonapeptide repeat 
sequences, and all were of the VK210 type. Notably, 
different nucleotide motifs, termed repeat allotypes, 
coded for the same VK210-type repeat units, indicat-
ing that some conservation is maintained at the amino 
acid level (putatively due to functional constraints), but 
not necessarily at the nucleotide level (Rich et al. 1997, 
2000). Most repeat units in the same csp allele were ei-
ther identical or nearly identical to each other, consist-
ent with their recent expansion in the repeat array. We 
found strong linkage disequilibrium at sites across the 
chromosome 8 segment flanking the csp locus, consist-
ent with rare meiotic recombination in this region. This 
suggests that repeat array diversity may not be severely 
constrained by low meiotic recombination rates that 
are typical in areas with low malaria endemicity. New 
repeat variants may be readily created by nonhomolo-
gous recombination events with potential implications 
for PvCSP-based vaccine development.
The MSP-1 and 3α are additional examples of blood-
stage vaccine-candidate antigens with repetitive arrays. 
The 200-kDa MSP 1 in P. vivax (PvMSP-1), originally 
described at the molecular level by del Portillo et al. 
(1991), is a major target of naturally acquired (Noguei-
ra et al. 2006) and vaccine-induced immunity (Yang 
et al. 1999, Herrera et al. 2007). The protein contains 
six highly polymorphic domains (4 of them repetitive) 
flanked by seven fairly conserved sequences (Putaporn-
tip et al. 2002) (Fig. 1). Sequence analysis has confirmed 
that blocks 1, 3 and 5 in PvMSP-1 are conserved at the 
protein level, while blocks 2, 4 and 6 are highly variable 
(Kolakovich et al. 1996, Figtree et al. 2000, Hoffmann et 
al. 2003, Bastos et al. 2007, Farooq et al. 2009, Kim et al. 
2009, Veron et al. 2009, Zakeri et al. 2010). 
The extensive sequence divergence in variable do-
mains of PvMSP-1 (amino acid similarity, 21-34%) has 
been maintained by balanced selection, most likely as a 
result of variant-specific immune pressure (Putaporntip 
et al. 2006). However, the extent to which PvMSP-1 se-
quence diversity affects immune recognition for this ma-
jor malaria-vaccine candidate antigen remains uncertain. 
To address this topic, we have recently compared natu-
rally acquired antibody responses to three polymorphic 
domains and the highly conserved PvMSP-1 C-terminal 
domain in a rural, malaria-exposed Amazonian cohort. 
We expressed 15 recombinant proteins corresponding 
to PvMSP-1 variants commonly found in local parasites 
and showed that less than one-third had detectable IgG 
antibodies to at least one expressed variant of blocks 2, 
6 and 10. However, 54.3% recognised the invariant C-
terminal domain PvMSP-119. Although the proportion 
of PvMSP-1 variant responders increased substantially 
during subsequent acute P. vivax infections, the spe-
cificity of IgG antibodies did not necessarily match the 
PvMSP-1 variant(s) found in infecting parasites (Bastos 
et al. 2007). The mechanisms underlying the limited im-
mune recognition of PvMSP-1 variants that are known to 
circulate in a given endemic area remain unclear. 
P. vivax evidences an allelic form diversity across 
the msp1 gene. In contrast, P. falciparum exhibits a clear 
allelic dimorphism over a long region in the msp1 lo-
cus (that is, sequences can be grouped into 1 of 2 major 
allelic types, MAD20 and K1) (Roy et al. 2008). Fre-
Fig. 2: a strand-slippage event in a repetitive sequence during mitotic 
DNA replication. The nascent (upper) strand becomes displaced from 
the parental (lower) strand during DNA replication and re-anneals out 
of phase, inserting a repeat motif (grey square) without changing non-
repetitive flanking sequences (grey rectangles). A similar slippage 
process in the parental strand would delete a one repeat motif from the 
nascent strand. These processes are suggested to generate variation 
in repeat arrays of surface malarial antigens, such as circumsporo-
zoite protein of Plasmodium vivax (PvCSP) and in minisatellite and 
microsatellite-type sequences.
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quent meiotic recombination events that shuffle differ-
ent sequence types to generate new alleles are respon-
sible for the mosaic structure of PvMSP-1 (Putaporntip 
et al. 1997, 2002). Recently, Han et al. (2011) compared 
PvMSP-1 alleles from re-emergent P. vivax parasites 
collected in the Republic of Korea over the past decade. 
They showed an increase in allelic diversity for variable 
domains of this protein, suggesting that recombination 
independently changed protein domains. Moreover, the 
greater similarity between allelic sequences within P. 
vivax than between P. vivax and closely related species 
was taken as evidence that polymorphisms in P. vivax 
arose recently. This is in stark contrast to the P. falci-
parum pattern, wherein different alleles are estimated to 
have diverged more than 25 million years ago (Polley et 
al. 2005). However, the cause for the large differences in 
this genetic history for these highly divergent parasites 
remains obscure. It may reflect either the significantly 
different sequence structure of the orthologues, differ-
ent molecular functions for the gene in the two species, a 
different population history, or another event.
Proteolytic processing of PvMSP-1 generates a C-ter-
minal fragment of 42 kDa (PvMSP-142), which is subse-
quently cleaved to generate two smaller fragments with ap-
parent molecular masses 33 kDa (PvMSP-133) and 19 kDa 
(PvMSP-119). Only the small, PvMSP-119 fragment remains 
at the merozoite surface during and after erythrocyte inva-
sion (Holder 2009). Limited polymorphism has been ob-
served in the C-terminal 19-kD PvMSP-1 fragment, with 
only two polymorphic sites (Soares et al. 1999, Dias et al. 
2011). PvMSP-142, like PfMSP-142, exhibits extensive ge-
netic polymorphism in natural infections (Escalante et al. 
1998, Conway et al. 2000, Putaporntip et al. 2002, Pacheco 
et al. 2007, Thakur et al. 2008, Dias et al. 2011).
The P. vivax msp3α gene encodes a MSP with an ap-
parent molecular mass ranging from 148-150 kDa. The 
protein contains an alanine-rich central domain that is pre-
dicted to form a coiled-coil tertiary structure (Galinski et 
al. 1999) (Fig. 1). The gene coding for the MSP-3α (PvMSP-
3α) is highly polymorphic and its variability has been as-
sessed by restriction fragment length polymorphism-PCR 
analysis (Bruce et al. 1999). The suitability of PvMSP-3α 
as a molecular marker has been confirmed in several geo-
graphic parasite populations: Papua New Guinea (Bruce et 
al. 1999), Thailand (Cui et al. 2003b, Mascorro et al. 2005), 
Pakistan and Iran (Zakeri et al. 2006, 2010, Khatoon et 
al. 2010), Venezuela (Ord et al. 2005), Peru (Sutton et al. 
2009), Colombia (Cristiano et al. 2008), India (Prajapati et 
al. 2010) and French Guiana (Veron et al. 2009). However, 
classifying restriction fragments according to size after 
electrophoresis is relatively subjective, which hampers 
large-scale analyses and reduces comparisons between 
studies. In addition, complex restriction patterns generated 
by mixed-clone infections may be difficult to interpret.
The P. vivax apical membrane antigen-1 (PvAMA-1) 
is an immunogenic, type 1 integral membrane protein, 
which is expressed at the apical surface of merozoites 
and sporozoites. It seems to play a role in erythrocyte 
and hepatocyte invasion (Hodder et al. 2001, Silvie et 
al. 2004). A number of studies have addressed polymor-
phism in that PvAMA-1 encoding gene in various parts 
of the world, such as Asia, Oceania and South America 
(Cheng & Saul 1994, Figtree et al. 2000, Han et al. 2002, 
Chung et al. 2003, Rodrigues et al. 2005, Gunasekera 
et al. 2007, Rajesh et al. 2007, Grynberg et al. 2008, 
Thakur et al. 2008, Moon et al. 2010). The PvAMA-1 
protein includes three extracellular domains, known as 
domains I, II and III (Pizarro et al. 2005) (Fig. 1). Most 
studies show a high degree of genetic variability in do-
main I (Ord et al. 2008, Thakur et al. 2008, Putaporntip 
et al. 2009), while the Sri Lanka domain II is the most 
polymorphic (Gunasekera et al. 2007). A comparison of 
PvAMA-1 domain I sequences from 320 worldwide iso-
lates revealed a striking divergence between Old World 
populations and those from Brazil (Grynberg et al. 2008, 
Putaporntip et al. 2009). Sequence analysis of Sri Lankan 
isolates suggested that balancing selection maintains 
polymorphism at the P. vivax ama1 locus (Gunasekera 
et al. 2007), while no strong evidence for balancing se-
lection was found in Thailand (Putaporntip et al. 2009). 
A number of studies have reported a substantially lower 
variability at this locus in P. vivax than in P. falciparum, 
implying that natural selection acts differently at this lo-
cus in the two species (Gunasekera et al. 2007, Ord et al. 
2008, Putaporntip et al. 2009). 
P. vivax DBP (PvDBP) plays an important role in the 
formation of an irreversible junction between P. vivax 
merozoites and its receptor, Duffy antigen/receptor for 
chemokines (DARC), at the surface of immature red 
blood cells (reticulocytes). This is a key step in host cell 
invasion (Singh et al. 2005, Galinski & Barnwell 2009). 
In vitro, antibodies against PvDBP inhibit DBP bind-
ing to DARC and block invasion of human erythrocytes 
(Michon et al. 2000, Grimberg et al. 2007, Ceravolo et al. 
2008). The most polymorphic segment of this protein is 
the erythrocyte-binding motif, a 170 amino-acid stretch 
located in the cysteine-rich domain II (Ranjan & Chitnis 
1999, VanBuskirk et al. 2004, Hans et al. 2005) (Fig. 1 ). 
This segment of the protein has been used as molecular 
marker in genetic population studies of field isolates from 
Papua New Guinea (Tsuboi et al. 1994, Xainli et al. 2000), 
Colombia (Ampudia et al. 1996), South Korea (Kho et al. 
2001), Brazil (Sousa et al. 2006, 2010) and Thailand (Gosi 
et al. 2008). Recently, the importance of selective diversi-
fying pressure has been shown for specific regions of the 
protein structure (Sousa et al. 2010).
Although molecular epidemiological studies using P. 
vivax gam1 gene have revealed variability in P. vivax iso-
lates from Sri Lanka (Snewin et al. 1995), Korea (Kho et 
al. 2001) and India (Prajapati et al. 2006), amplification 
of this gene has been associated with artefacts (Imwong 
et al. 2001, 2005). For this reason, P. vivax gam1 is no 
longer used as a reliable genetic marker. 
Neutral or nearly neutral molecular markers - Feng 
et al. (2003) described 33 tandem repeat (TR) arrays 
consisting of repeat units with four or more nucleotides. 
However, not much diversity was revealed by analysing 
these arrays in four monkey-adapted P. vivax strains 
(India VII, Salvador-I, Belem, Thai-NYU). Leclerc et 
al. (2004) used the eight most polymorphic TR loci de-
scribed by Feng et al. (2003) to show much more vari-
ability in TRs than microsatellites in isolates from dif-
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ferent endemic areas. However, little TR diversity was 
found within populations (Tables II, III). Rezende et 
al. (2009) selected the five most polymorphic loci from 
Leclerc’s study for their analysis of field isolates from 
four regions in Brazil. This set of TR markers again 
revealed relatively little diversity in Brazilian isolates 
(Table III). Most TR markers had a clearly predomi-
nant allele. Moreover, these markers were inefficient in 
detecting multiple-clone infections and were unable to 
group the isolates according to their geographical ori-
gin (Rezende et al. 2009). As these TR markers map to 
a 100-kb region in chromosome 8 with many putative 
protein-coding genes (including csp), natural selection is 
expected to affect them, even if indirectly, as a result of 
hitchhiking (Feng et al. 2003). Thus, these loci may not 
be effectively neutral given their proximity to sequences 
under strong diversifying or purifying selection (Leclerc 
et al. 2004). An alternative explanation for the low vari-
ability in TR loci may include their structure, as they are 
relatively short arrays consisting of long (> 6 bp) repeat 
units. These sequences are less prone to strand slippage 
events (Fig. 2) than typical microsatellite-type sequenc-
es consisting of long arrays of short repeat motifs. 
The current markers of choice for large-scale popula-
tion genetic studies in eukaryotes are highly polymorphic 
and short (1-6 bp-long) TRs, known as microsatellites 
(Schlötterer 1998). In contrast to the ~1,000 polymorphic 
microsatellite loci currently available for P. falciparum 
typing, it was demonstrated that a few dozen microsatel-
lite loci are polymorphic in P. vivax field isolates (Table 
II). Despite these limitations, microsatellite-based stud-
ies of the parasite have provided valuable information on 
P. vivax population structure and diversity in the Ameri-
cas, Asia and Africa (Ferreira et al. 2007, Karunaweera 
et al. 2007, 2008, Koepfli et al. 2009, Orjuela-Sánchez et 
al. 2009a, Gunawardena et al. 2010, Rezende et al. 2010, 
Van den Eede et al. 2010a, b, 2011).
The first microsatellite described for P. vivax was 
a dinucleotide (AT) repeat, used to identify high vari-
ability in 89 isolates from Papua New Guinea (Gómez 
et al. 2003) (Tables II, III). Leclerc et al. (2004) reported 
low variability in dinucleotide microsatellite loci. In this 
study, only one of 13 microsatellites showed extensive 
variability and nine were entirely monomorphic among 
the eight P. vivax populations analysed (Table III). Us-
ing a draft of the unpublished P. vivax genome, Imwong 
et al. (2006) designed primer pairs for 11 dinucleotide 
microsatellites and showed extensive variability in P. 
vivax populations from areas with intermediate to high 
levels of endemicity. They compared their findings with 
those of Leclerc et al. (2004) and explained the discrep-
ancy in microsatellite diversity levels as the result of 
repeat array length at the loci studied. They suggested 
that microsatellite diversity correlates positively repeat 
array length, as the rate of strand-slippage events that 
create diversity increases exponentially with repeat ar-
ray lengths. Recently, Rezende et al. (2010) corroborated 
this hypothesis using a set of microsatellites with di, tri 
and tetra nucleotide repeat units. They highlighted the 
importance of microsatellite loci structure in genetic 
diversity studies using malaria parasites. Karunaweera 
et al. (2007) described a new set of highly polymorphic 
TABLE II
Description of molecular markers: minisatellites and microsatellites  
used in genetic population analysis of Plasmodium vivax field isolates
Group of 
molecular 
markers
Number of microsatellites
Genomic regions
Types of repeat unit
(imperfect and/or composed)b
ReferencesCoding (hypothetical)a Non-coding Total Di Tri Tetra > 4
I 4 (2) 4 8c 0 1 (1) 3 4 Feng et al. (2003)
II 1 0 1 1 0 0 0 Gomez et al. (2003)
III 1 12 13 13 (9) 0 0 0 Feng et al. (2003)
IV 2 (1) 6 11d 11 0 0 0 Imwong et al. (2006)
V 2 (1) 6 8 0 1 3 4 Imwong et al. (2007)
VI 13 (9) 1 14 0 13 (7) 1 (1) 0 Karunaweera et al. (2007)
VII 7 (2) 17 24 7 (2) 10 (3) 6 1 Joy et al. (2008)
VIII 4 (3) 7 11 4 3 4 0 Rezende et al. (2010)
IX 3 (2) 0 3 0 3 (1) 0 0 Van den Eede et al. (2010a)
a: number of microsatellites lying in hypothetical proteins among the microsatellites which lie in coding regions; b: number of 
microsatellites imperfect and/or composed among the total number of microsatellites, with different repeat unit sizes [dinucle-
otides (Di), trinucleotides (Tri) and tetranucleotides (Tetra) or more than 4 nucleotides]; c: in the original manuscript, these 
molecular markers were designated as tandem repeats, including minisatellites and microsatellites; d: three loci could not be 
assigned to chromosomes.
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tricleotide and tetranucleotide microsatellites, which are 
expected to yield more accurate allele scores than dinu-
cleotide markers (Anderson et al. 1999).
P. vivax genome sequencing allowed for further char-
acterisation of a panel including ~160 microsatellites 
(Carlton et al. 2008). While searching for a repeat unit with 
2-6 nucleotides, the authors found only one microsatel-
lite locus with repeats consisting of more than four nucle-
otides. Most (76%) loci had perfect repeat units (Fig. 3A), 
in contrast with the markers described by Karunaweera 
et al. (2007). All except one microsatellite were assigned 
to chromosomes, but their chromosome distribution was 
clearly heterogeneous. Chromosomes 1 and 4 had the 
lowest marker density, whereas chromosomes 14 and 9 
had the highest density (Fig. 3B). Despite the relatively 
low AT content in the P. vivax genome, when compared 
with that of P. falciparum, P. vivax microsatellite-type 
repeats are particularly AT-rich (Fig. 3C). To character-
ise polymorphic microsatellite markers, these loci were 
analysed in eight monkey-adapted P. vivax strains (Bra-
zil I, Miami II, Pakchong, Panama I, Nicaragua, Thai II, 
Vietnam IV and Indonesia XIX). Nineteen markers were 
monomorphic among these samples, none were polymor-
phic in all strains and the large majority of markers were 
polymorphic only in 2-4 strains (Fig. 3D). Further, only 
one-fourth of the markers shown to be polymorphic in 
natural P. vivax populations were also identified as poly-
morphic using these eight P. vivax strains.
High variability in P. vivax isolates has been demon-
strated using different sets of microsatellites (Table III). 
However, this comparison is complicated, as it is difficult 
to determine how much of the variation depends on the 
set of markers and how much is due to genetic diversity 
in the studied populations (Imwong et al. 2007a, Koep-
fli et al. 2009). Currently, the most widely used markers 
are a set of 14 polymorphic microsatellites described by 
Karunaweera et al. (2007), which were used to analyse 
the population structures of P. vivax in Brazil, Vietnam, 
Sri Lanka, Myanmar, Ethiopia and Peru (Ferreira et al. 
2007, Karunaweera et al. 2008, Gunawardena et al. 2010, 
Van den Eede et al. 2010a, b, 2011). Using the same set 
of markers, similar variability was detected in different 
geographical areas, with HE ranging from 0.71 in Bra-
zil to 0.86 in Myanmar and Vietnam; only Peru showed 
a slightly lower variability (HE = 0.58). More recently, 
Joy et al. (2008) selected 24 microsatellites of ~160, de-
scribed by Carlton et al. (2008), and used them to show 
local adaptation between mosquito vectors and different 
genetic populations of P. vivax from Mexico. There was 
no correlation between the number of alleles identified by 
Carlton et al. (2008) and the variability identified using a 
large number of P. vivax field isolates using the same set 
of markers by Joy et al. (2008). These data reinforce the 
uncertainty in using laboratory strains to identify poly-
morphic markers (Fig. 4). Koepfli et al. (2009) showed 
high variability in Papua New Guinea isolates using this 
TABLE III
Genetic variability analysis of Plasmodium vivax field populations using minisatellites and microsatellites as molecular markers
MM group
(n) n
Geographical origin of isolates 
(n)
Allelesa
n HE MI References
I 96 AZE (37), THAI (15), TUR (16), 
VEN(16), ETH(8)
1-8 0.26-0.67 NA Leclerc et al. (2004)
I (5) 44 BRA 2-9 0.57 0-66 Rezende et al. (2009)
II 89 PNG 15 0.85 4.5 Gomez et al. (2003)
III 108 AZE (40), THAI (20), TUR (19), VEN (18), 
ETH (7), MOZ (1), PNG (1), SRL (1)
1-9 0.35-0.80 NA Leclerc et al. (2004)
IV 82 COL (27), IND (27), THAI (28) 7-18 0.64-0.77 NA Imwong et al. (2006)
V 345 IND (90), LAO (81), THAI (92), COL (82) 9-35 0.72-0.79 40-80 Imwong et al. (2007)
VI 25 SRL 6-13 0.78 NA Karunaweera et al. (2007)
VI 74 BRA 3-14 0.71 48 Ferreira et al. (2007)
VI 132 SRL (50), BRA (74), VIET (8) 9-43 0.65-0.908 60b Karunaweera et al. (2008)
VI (12) 425 SRI (140), MYA (167), ETH (118) 3-44 0.75-0.86 65 Gunawardena et al. (2010)
VII 234 MEX 4-8d 0.61 16 Joy et al. (2008)
V (2), VI (1) 93-108 PNG 13-67 0.93 NA Koefli et al. (2009)
VIII 53 BRA 4-31 0.71 60 Rezende et al. (2010)
VI, IX 69 VIET 6-41 0.86 100c Van den Eede et al. (2010a)
VI, IX 94 PER 2-8 0.58 11-70c Van den Eede et al. (2010b)
a: number of alleles per locus only in P. vivax isolates; b: data for samples collected in 2005; c: including all observed alleles above 
100 arbitrary fluorescence units (except for MS16 -> 25%); d: average per locus; AZE: Azerbaijan; BRA: Brazil; COL: Colombia; 
ETH: Ethiopia; HE: heterozigosity expected per population using the set of polymorphic markers; IND: India; LAO: Lao; MEX: 
Mexico; MI: multiple clone infections; MM: molecular marker group defined in Table I (number of markers used was provided 
only if was not used all markers of the group); MOZ: Mozambique; MYA: Myanmar; n: number of isolates; NA: not available; PER: 
Peru; PNG: Papua New Guinea; SRL: Sri Lanka; THAI: Thailand; TUR: Turkey; VEN: Venezuela; VIET: Vietnam.
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set of microsatellites and three selected from other studies 
(Table II). Rezende et al. (2010) described a set of 11 mi-
crosatellites used to show a positive correlation between 
transmission levels and genetic variability in P. vivax iso-
lates from geographical regions in Brazil. Taken together, 
these data suggest that, regardless of endemicity in the 
isolates’ geographical origin, most studies show that P. 
vivax populations are highly variable across the globe.
Practical uses for P. vivax genotyping - The vast 
field of infectious disease molecular epidemiology has 
produced a number of examples involving practical ap-
plications for molecular markers in addressing issues of 
clear biological and public health importance. Here, we 
briefly review four areas of potential interest: (i) detec-
tion of naturally occurring multiple-clone infections, (ii) 
after-treatment follow-up in clinical trials, (iii) between-
species comparisons of genetic diversity levels and (iv) 
tracking of the geographic origin of infections. 
Over the last two decades, molecular markers have 
revealed that many natural P. vivax infections comprise a 
complex mixture of clonal populations; that is, multiple-
clone vivax infections are fairly common in human hosts 
(Havryliuk & Ferreira 2009). The earliest attempts to in-
vestigate the clonal diversity of P. vivax isolates in human 
infections focused on characterisation of phenotypes us-
ing monoclonal antibodies or isoenzymes (Udagama et 
al. 1987, 1990, Joshi et al. 1989), an approach that required 
blood samples with relatively high parasitaemias. As a 
rule, multilocus analysis, such as microsatellite typing, 
detects more multiple-clone infections than single-locus 
analysis, and augmenting the number of markers increas-
es the chance of detecting multiple clones. For example, 
in 90 P. vivax isolates from Thailand, Cui et al. (2003b) 
found a multiple-clone infection rate of 25.6% using the 
PvCSP encoding gene alone, 19.3% using PvMSP-3α 
alone and 35.6% when the markers were combined. Par-
ticularly surprising is the extensive clonal diversity of 
P. vivax infections in areas with relatively low malaria 
transmission, such as Brazil, Colombia and Sri Lanka 
(Ferreira et al. 2007, Imwong et al. 2007b, Karunaweera 
et al. 2008, Orjuela-Sánchez et al. 2009a, Gunawardena 
et al. 2010). The evolutionary and epidemiological con-
sequences of multiple-clone P. vivax infections have not 
been well-investigated. However, experimental rodent 
malaria models suggest that, for two or more genetically 
distinct clones in the same host, intra-host competition 
for limited resources may select for P. vivax traits repre-
Fig. 3: characterisation of microsatellites identified in the Plasmodium vivax genome project (Carlton et al. 2008). A: number of microsatel-
lites with repeat units composed of either 2, 3, 4 or > 4 nucleotides. Microsatellites were also divided into either perfect (with only 1 type of 
tandem repeat unit), composed (comp) (with more than 1 type of repeat unit) or imperfect (imp) (repeat units interspersed with nucleotides); 
B: distribution of the number of microsatellites among P. vivax chromosomes, including those identified by the genome project, previously 
described, and present in both; C: positive correlation between percentage of microsatellites and AT content in the repeat units; D: percentage 
of microsatellites with different numbers of alleles, analysing eight P. vivax laboratory lines (Carlton et al. 2008). 
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senting major public health challenges, such as increased 
virulence, transmissibility and antimalarial drug resist-
ance (reviewed by Havryliuk & Ferreira 2009).
Molecular markers have also been used to type P. 
vivax infections after drug treatment. Reappearance of 
parasitaemia after drug treatment can result from either 
recrudescence of surviving asexual blood-stage parasites; 
relapse from dormant liver stages, known as hypnozoites; 
or new infections with unrelated parasites. Paired parasite 
molecular genotyping distinguishes between recrudes-
cences (with the same genotype as the initial infection) 
and new infections (with a different genotype). Until re-
cently, relapses were thought to be caused by hypnozoites 
that are genetically identical to the blood-stage parasites 
found in primary infections (Craig & Kain 1996, Kirch-
gatter & del Portillo 1998). This suggested that molecular 
methods could easily discriminate relapses, which would 
have the same genotype as the primary infection, from 
new infections, which would have a different genotype. 
This view has been challenged by the recent discovery 
of different parasite genotypes in primary infections and 
relapses for 72% of P. vivax-infected patients from Thai-
land, India and Myanmar (Imwong et al. 2007b). Accu-
rate detection of multiple-clone P. vivax infections is even 
more important in light of this report. If the primary in-
fection comprises multiple clones, then some of them 
may have been missed or partially characterised or, even 
worse, had their alleles combined to create artificial hap-
lotypes during genotyping. Likewise, the relapsing clone 
could have been either missed or incorrectly typed dur-
ing the primary infection, leading to a false conclusion 
that different genotypes were present during the primary 
and relapse infections. The current consensus is that re-
lapses may originate from reactivation of either the same 
parasite clone found in the primary bloodstream infection 
(homologous hypnozoites) or another, genetically different 
clone (heterologous hypnozoites). Our recent microsatel-
lite analysis of 28 paired acute-infection and recurrence 
parasites from rural Amazonia revealed only two pairs of 
identical haplotypes (consistent with recrudescences or 
reactivation of homologous hypnozoites) and four pairs of 
related haplotypes (sharing alleles at 11-13 of 14 microsat-
ellites analysed) (Orjuela-Sánchez et al. 2009a).
As the characteristics of endemic settings may in-
fluence the genetic diversity of the parasite, noteworthy 
findings could be obtained from sympatric P. vivax and 
P. falciparum isolates that are analysed using similar 
protocols. Two comparisons of microsatellite diversity 
in human malaria parasite species co-circulating in the 
same area in Brazil have been published. Both suggest 
that P. vivax infections are more diverse (that is, they 
comprise a higher number of alleles and virtual HE) and 
comprise multiple clones more often than P. falciparum 
infections in rural Amazonia (Ferreira et al. 2007, Or-
juela-Sánchez et al. 2009b). As P. vivax currently pre-
dominates in Brazil, differences in species-specific 
transmission levels might translate into differences in 
genetic diversity. However, we recently found more mi-
crosatellite diversity in P. vivax compared with P. fal-
ciparum populations in western Cambodia, where both 
species are similarly prevalent (MU Ferreira and RM 
Fairhurst, unpublished observations). Thus, we suggest 
that the higher microsatellite diversity found in P. vivax 
isolates may reflect greater plasticity in microsatellite-
type short repeats for this species.
Finally, standardised molecular methods applied to 
worldwide populations may also help characterise popu-
lation or region-specific molecular barcodes. This is es-
sential for tracking the geographic origin of infections. 
A microsatellite-based analysis of P. vivax samples from 
Sri Lanka, Ethiopia and Myanmar recently showed that 
parasites may be classified as originating from Asia or 
Africa with 70-80% accuracy. This suggests that micros-
atellite data might be useful in predicting the origin of P. 
vivax parasites (Gunawardena et al. 2010). Further analy-
ses are required to confirm whether microsatellite-based 
molecular barcodes are useful for determining whether 
particular infections were either transmitted locally or 
imported into areas approaching the elimination phase.
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